Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 23 | 2017 | 1854 | 3.590 |
Why?
|
| DNA Breaks | 6 | 2017 | 25 | 1.860 |
Why?
|
| Phagocytosis | 6 | 2017 | 189 | 1.820 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2025 | 70 | 1.810 |
Why?
|
| Fluorescent Dyes | 8 | 2017 | 248 | 1.790 |
Why?
|
| DNA Damage | 12 | 2017 | 520 | 1.700 |
Why?
|
| In Situ Nick-End Labeling | 8 | 2017 | 120 | 1.550 |
Why?
|
| DNA | 10 | 2017 | 1412 | 1.530 |
Why?
|
| Staining and Labeling | 8 | 2017 | 167 | 1.400 |
Why?
|
| Phagocytes | 3 | 2017 | 25 | 1.050 |
Why?
|
| Biological Assay | 2 | 2017 | 107 | 0.970 |
Why?
|
| Deoxyribonucleases | 2 | 2025 | 21 | 0.970 |
Why?
|
| Tissue Fixation | 4 | 2017 | 38 | 0.950 |
Why?
|
| Molecular Probe Techniques | 4 | 2017 | 23 | 0.930 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 304 | 0.900 |
Why?
|
| DNA Probes | 8 | 2014 | 118 | 0.880 |
Why?
|
| Oligonucleotide Probes | 6 | 2014 | 85 | 0.850 |
Why?
|
| Thymus Gland | 6 | 2017 | 100 | 0.840 |
Why?
|
| DNA Topoisomerases | 3 | 2014 | 4 | 0.800 |
Why?
|
| Endodeoxyribonucleases | 4 | 2017 | 47 | 0.750 |
Why?
|
| DNA Fragmentation | 5 | 2002 | 55 | 0.700 |
Why?
|
| Polymerase Chain Reaction | 3 | 2017 | 1457 | 0.690 |
Why?
|
| Nanotechnology | 2 | 2014 | 50 | 0.650 |
Why?
|
| Cell Death | 3 | 2017 | 235 | 0.630 |
Why?
|
| Formaldehyde | 2 | 2017 | 50 | 0.580 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2014 | 22 | 0.510 |
Why?
|
| Extracellular Vesicles | 1 | 2017 | 69 | 0.460 |
Why?
|
| Lysosomes | 1 | 2017 | 269 | 0.440 |
Why?
|
| Rats | 12 | 2017 | 3413 | 0.410 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2014 | 141 | 0.410 |
Why?
|
| Cell Nucleus | 2 | 2014 | 562 | 0.380 |
Why?
|
| Caspases | 2 | 2003 | 157 | 0.360 |
Why?
|
| Genetic Techniques | 2 | 2011 | 97 | 0.350 |
Why?
|
| Polyethyleneimine | 2 | 2014 | 10 | 0.340 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 367 | 0.330 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2011 | 86 | 0.320 |
Why?
|
| Adrenal Cortex | 3 | 1999 | 10 | 0.310 |
Why?
|
| Protein Transport | 2 | 2014 | 364 | 0.310 |
Why?
|
| Cyclins | 3 | 1999 | 93 | 0.300 |
Why?
|
| Vaccinia virus | 3 | 2014 | 50 | 0.290 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2006 | 296 | 0.290 |
Why?
|
| Molecular Probes | 2 | 2006 | 26 | 0.280 |
Why?
|
| DNA Ligases | 2 | 2012 | 15 | 0.270 |
Why?
|
| In Situ Hybridization | 2 | 2006 | 445 | 0.260 |
Why?
|
| Animals | 22 | 2017 | 33937 | 0.260 |
Why?
|
| Biomarkers | 1 | 2017 | 3400 | 0.260 |
Why?
|
| Reperfusion Injury | 2 | 1999 | 109 | 0.250 |
Why?
|
| Brain Ischemia | 2 | 2014 | 263 | 0.250 |
Why?
|
| Horseradish Peroxidase | 1 | 2006 | 14 | 0.240 |
Why?
|
| Quantum Dots | 1 | 2006 | 16 | 0.240 |
Why?
|
| Nanotubes | 1 | 2006 | 16 | 0.240 |
Why?
|
| Cell Membrane | 2 | 2005 | 451 | 0.240 |
Why?
|
| Stroke | 1 | 2014 | 1051 | 0.240 |
Why?
|
| Macrophages | 3 | 2017 | 653 | 0.240 |
Why?
|
| Povidone | 1 | 2005 | 6 | 0.230 |
Why?
|
| Nanotubes, Carbon | 1 | 2005 | 15 | 0.230 |
Why?
|
| Materials Testing | 1 | 2005 | 80 | 0.230 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2002 | 77 | 0.220 |
Why?
|
| Necrosis | 3 | 2003 | 194 | 0.210 |
Why?
|
| Phagosomes | 2 | 2017 | 37 | 0.210 |
Why?
|
| Nucleic Acid Conformation | 3 | 2002 | 181 | 0.210 |
Why?
|
| Transfection | 1 | 2005 | 947 | 0.200 |
Why?
|
| Thimerosal | 1 | 2003 | 3 | 0.200 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2003 | 11 | 0.200 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 57 | 0.190 |
Why?
|
| DNA, Single-Stranded | 2 | 1993 | 71 | 0.190 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 157 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2005 | 856 | 0.190 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 284 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2017 | 2907 | 0.180 |
Why?
|
| Glioblastoma | 2 | 2005 | 357 | 0.180 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2002 | 96 | 0.170 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 1594 | 0.160 |
Why?
|
| Ligases | 1 | 1999 | 35 | 0.160 |
Why?
|
| Humans | 20 | 2025 | 130857 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 564 | 0.150 |
Why?
|
| Fluorescence | 2 | 2014 | 95 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 3 | 2005 | 964 | 0.140 |
Why?
|
| Biotin | 2 | 1998 | 39 | 0.140 |
Why?
|
| Chromosome Breakage | 1 | 1998 | 156 | 0.130 |
Why?
|
| Molecular Biology | 1 | 1998 | 66 | 0.130 |
Why?
|
| Cathepsin D | 1 | 2017 | 16 | 0.130 |
Why?
|
| Cell Survival | 2 | 2014 | 840 | 0.130 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 26 | 0.130 |
Why?
|
| Digoxigenin | 1 | 1996 | 2 | 0.120 |
Why?
|
| Adamantane | 1 | 1996 | 9 | 0.120 |
Why?
|
| Neurons | 2 | 2003 | 2008 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 62 | 0.120 |
Why?
|
| Proteolysis | 1 | 2017 | 194 | 0.120 |
Why?
|
| Histocytochemistry | 1 | 2014 | 83 | 0.110 |
Why?
|
| Anions | 1 | 2014 | 15 | 0.100 |
Why?
|
| Cations | 1 | 2014 | 38 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 411 | 0.100 |
Why?
|
| Nylons | 1 | 1993 | 11 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 1993 | 27 | 0.100 |
Why?
|
| Polyethylenes | 1 | 1993 | 7 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1695 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2014 | 339 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2003 | 127 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 1316 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1999 | 1136 | 0.090 |
Why?
|
| Vaccinia | 1 | 2012 | 8 | 0.090 |
Why?
|
| Energy Transfer | 2 | 2002 | 16 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 733 | 0.090 |
Why?
|
| DNA Polymerase I | 1 | 2011 | 10 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2011 | 27 | 0.080 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 42 | 0.080 |
Why?
|
| Cell Line | 1 | 2014 | 2572 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 1999 | 80 | 0.080 |
Why?
|
| Dexamethasone | 2 | 2002 | 253 | 0.070 |
Why?
|
| Male | 10 | 2017 | 64722 | 0.070 |
Why?
|
| Lymphoma | 1 | 2011 | 331 | 0.070 |
Why?
|
| Base Sequence | 3 | 2002 | 2746 | 0.070 |
Why?
|
| Cattle | 3 | 1996 | 501 | 0.060 |
Why?
|
| Enzymes, Immobilized | 1 | 2006 | 6 | 0.060 |
Why?
|
| Wilms Tumor | 2 | 1998 | 117 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 31 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3705 | 0.060 |
Why?
|
| Avidin | 1 | 2005 | 12 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 40 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2005 | 13 | 0.060 |
Why?
|
| Optical Devices | 1 | 2005 | 2 | 0.060 |
Why?
|
| Hydrazines | 1 | 2005 | 30 | 0.060 |
Why?
|
| Particle Size | 1 | 2005 | 137 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4669 | 0.050 |
Why?
|
| Polymers | 1 | 2005 | 111 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2005 | 171 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2017 | 4674 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 31 | 0.050 |
Why?
|
| Deoxyribonucleotides | 1 | 2003 | 7 | 0.050 |
Why?
|
| Freezing | 1 | 2003 | 27 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 85 | 0.050 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2002 | 7 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 22 | 0.050 |
Why?
|
| Dihydroorotase | 1 | 2002 | 7 | 0.050 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2002 | 7 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2002 | 28 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2002 | 96 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 33 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 76 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 66 | 0.050 |
Why?
|
| Brain | 1 | 2014 | 3226 | 0.040 |
Why?
|
| Cardiac Output, Low | 2 | 2000 | 59 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 115 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 172 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2005 | 8570 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 78 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 340 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 423 | 0.040 |
Why?
|
| Skin | 1 | 2003 | 547 | 0.040 |
Why?
|
| Biotinylation | 1 | 1999 | 20 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1999 | 20 | 0.040 |
Why?
|
| Cyclin E | 1 | 1999 | 31 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 460 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 412 | 0.040 |
Why?
|
| Mice | 3 | 2014 | 18245 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1623 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 233 | 0.040 |
Why?
|
| Time Factors | 2 | 2002 | 6242 | 0.040 |
Why?
|
| Complement C1q | 1 | 1999 | 18 | 0.040 |
Why?
|
| Complement Activation | 1 | 1999 | 47 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1999 | 111 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 593 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 249 | 0.030 |
Why?
|
| Autolysis | 1 | 1996 | 1 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 483 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1996 | 39 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1999 | 403 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1996 | 5 | 0.030 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 1996 | 11 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 1996 | 56 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2000 | 356 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 141 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1996 | 95 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 72 | 0.030 |
Why?
|
| Tissue Donors | 1 | 1999 | 501 | 0.030 |
Why?
|
| Motor Activity | 1 | 1999 | 500 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 310 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 642 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1996 | 211 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 700 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1998 | 360 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 809 | 0.030 |
Why?
|
| Gene Expression | 2 | 1996 | 1489 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2127 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1993 | 54 | 0.030 |
Why?
|
| Filtration | 1 | 1993 | 21 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1993 | 94 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1998 | 973 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1996 | 2558 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1993 | 291 | 0.020 |
Why?
|
| Melanoma | 1 | 1999 | 920 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1996 | 803 | 0.020 |
Why?
|
| Kidney | 1 | 1998 | 1286 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1998 | 15016 | 0.020 |
Why?
|
| Mutation | 1 | 2001 | 6151 | 0.020 |
Why?
|
| Child | 2 | 1999 | 26223 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 812 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 2398 | 0.010 |
Why?
|
| Disease Progression | 2 | 2000 | 2204 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 3488 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2000 | 52 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 271 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2000 | 109 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 364 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 57 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1999 | 53 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1999 | 109 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 83 | 0.010 |
Why?
|
| Cell Communication | 1 | 2000 | 186 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1998 | 34 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 139 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 619 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 271 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 778 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 576 | 0.010 |
Why?
|
| Middle Aged | 1 | 1996 | 28513 | 0.010 |
Why?
|
| RNA | 1 | 1999 | 518 | 0.010 |
Why?
|
| Echocardiography | 1 | 2000 | 1139 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1995 | 172 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 1995 | 216 | 0.010 |
Why?
|
| Heart | 1 | 1998 | 666 | 0.010 |
Why?
|
| Female | 1 | 1998 | 70681 | 0.000 |
Why?
|